Patents Assigned to BeyondSpring Phamaceuticals, Inc.
  • Therapeutic compositions and methods for treating checkpoint inhibitor-resistant tumors using plinabulin-based combination therapies
    Patent number: 12377094
    Abstract: Disclosed herein are methods of treating, preventing or ameliorating a disease or condition associated with cancer or a tumor. In some embodiments, the method includes administering a compound of Formula (I) to a subject in need thereof wherein the cancer or the tumor is or becomes resistant to one or more immune checkpoint inhibitors.
    Type: Grant
    Filed: November 19, 2024
    Date of Patent: August 5, 2025
    Assignee: BeyondSpring Phamaceuticals, Inc.
    Inventors: Lan Huang, Ramon Mohanlal, James R. Tonra